Salivary Gland Tumor Fusion Panel with Interpretation
Label Mnemonic: SGTF
Epic code: LAB8690
Downtime form: A-1a Doctor-Provider Orders - Pathology Microbiology
Molecular Pathology
6240 RCP
384-9568
Specimen(s):
Formalin-fixed, paraffin embedded tissue block, or 10 unstained 4 micron-thick section on non-plus slides and one H&E stained section or Fine needle aspirate
Rejection Criteria:
Specimens that have been decalcified will not be accepted.
Testing Schedule:
Weekly
Turn Around Time:
21 days
Reference Range:
Fusion or mutation not detected.
Interpretive Data:
Detected
Not detected
Comments:
Tissue sections are reviewed by a pathologist. RNA is isolated from the selected area of the sample. Anchored multiplex PCR for a targeted next-generation sequencing is performed. The sequenced sample is a reverse transcription PCR-amplified fragenbt library in which each sample is uniquely identified by ligation of a short oligonucleotide barcode. The resultant sequence identifies the exons of the fusion transcript arising from the specific gene target and the partnet gene.

The panel target gene rearrangements of these gene targets: ETV6, EWSR1, HMGA2, HRAS, MAML2, MYB, MYBL1, NFIB, NTRK3, NUTM1, PLAG1, PRKD1, PRKD2, PRKD3.
Methodology:
Massively paraellel Next Generation RNA sequencing by synthesis, semiconductor technology, Illumia
CPT Code:
81445